Abstract
Selectivity of tamsulosin and terazosin to functional alpha1-adrenoceptors was examined. Both drugs competitively inhibited the contractile responses to noradrenaline in different tissues where the responses were mediated through the alpha1D-, alpha1B- or alpha1L-subtype. Together with the affinities obtained in the binding study with cloned (alpha1a, alpha1b, alpha1d) and native (alpha1A and alpha1B) subtypes, the selectivity of tamsulosin was alpha1A>alpha1L, alpha1D>alpha1B. Terazosin had lower affinity at various subtypes than tamsulosin, but showed relatively high selectivity to the alpha1D-subtype. In the human prostate, tamsulosin was more than 30-fold higher in affinity than terazosin in functional and binding studies.
Publication types
-
Comparative Study
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adrenergic alpha-Antagonists / metabolism
-
Adrenergic alpha-Antagonists / pharmacology*
-
Animals
-
Aorta, Thoracic / drug effects
-
Aorta, Thoracic / metabolism
-
Aorta, Thoracic / physiology
-
Binding, Competitive
-
Dogs
-
Dose-Response Relationship, Drug
-
Humans
-
Male
-
Muscle Contraction / drug effects
-
Norepinephrine / pharmacology
-
Prazosin / analogs & derivatives
-
Prazosin / pharmacology
-
Prostate / drug effects
-
Prostate / metabolism
-
Prostate / physiology
-
Rabbits
-
Rats
-
Receptors, Adrenergic, alpha-1 / metabolism
-
Sulfonamides / metabolism
-
Sulfonamides / pharmacology*
-
Tamsulosin
Substances
-
ADRA1A protein, human
-
ADRA1B protein, human
-
ADRA1D protein, human
-
Adrenergic alpha-Antagonists
-
Receptors, Adrenergic, alpha-1
-
Sulfonamides
-
Terazosin
-
Tamsulosin
-
Norepinephrine
-
Prazosin